Company Filing History:
Years Active: 2017-2018
Title: The Innovations of Toru Kurosawa
Introduction
Toru Kurosawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of dysphagia treatment. With a total of 3 patents to his name, Kurosawa's work is recognized for its innovative approach to improving patient care.
Latest Patents
Kurosawa's latest patents focus on local administration-type pharmaceuticals aimed at improving dysphagia. One of his key inventions is a dysphagia improving composition characterized by the administration of a substance that inhibits angiotensin converting enzyme, which is known to degrade substance P. This composition is designed to be administered locally in a dosage that does not influence blood pressure. Another patent also revolves around a pharmaceutical for improving dysphagia, emphasizing the same innovative composition and its benefits.
Career Highlights
Kurosawa is currently associated with Meiji Seika Pharma Co., Ltd., where he continues to develop groundbreaking solutions in the pharmaceutical industry. His work has garnered attention for its potential to enhance the quality of life for individuals suffering from swallowing difficulties.
Collaborations
Some of his notable coworkers include Koichi Kitamura and Maho Kondo, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Toru Kurosawa's contributions to the field of pharmaceuticals, particularly in dysphagia treatment, highlight his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to advancing medical science and enhancing the lives of those in need.